Focus Group Testing to Effectively Plan and Tailor Cancer Prevention and Control Communication Campaigns--New

ICR 201111-0920-004

OMB: 0920-0800

Federal Form Document

Forms and Documents
Document
Name
Status
Form
New
Form
New
Supporting Statement B
2011-10-19
Supplementary Document
2011-10-19
Supplementary Document
2011-10-19
Supplementary Document
2011-10-19
Supplementary Document
2011-10-19
Supplementary Document
2011-10-19
Supplementary Document
2011-10-19
Supplementary Document
2011-10-19
Supplementary Document
2011-10-19
Supplementary Document
2011-10-19
Supplementary Document
2011-10-19
Supplementary Document
2011-10-19
Supporting Statement A
2011-10-19
ICR Details
0920-0800 201111-0920-004
Historical Active 200906-0920-015
HHS/CDC
Focus Group Testing to Effectively Plan and Tailor Cancer Prevention and Control Communication Campaigns--New
Extension without change of a currently approved collection   No
Regular
Approved without change 11/28/2011
Retrieve Notice of Action (NOA) 11/22/2011
Previous terms of clearance continue: This generic clearance for HHS/CDC Focus Group Testing to Effectively Plan and Tailor Cancer Prevention and Control Communication Campaigns is approved under the following conditions: 1) HHS/CDC shall use the generic clearance to collect general public and health care professionals data (via focus groups) where the agency seeks to gather information for general service improvement, not for publication or for the purpose of informing significant policy or resource allocation decisions. 2) Focus groups should be of limited size and scope. 3) For individual focus groups, HHS/CDC shall submit a generic IC in ROCIS along with an abbreviated supporting statement in the template agreed to by OMB and HHS/CDC. This statement shall include all relevant information, including a statement of need, intended use of information, description of respondents, information collection procedures, expected response rate, justification for incentive, and estimated burden. 4) OMB will aim to respond with clearance or questions within 10 working days.
  Inventory as of this Action Requested Previously Approved
11/30/2014 30 Months From Approved 01/31/2012
2,592 0 2,592
1,814 0 1,814
52,843 0 52,843

CDC's Division of Cancer Prevention and Control requests OMB approval for a generic clearance to conduct formative evaluation efforts in order to effectively plan new and/or tailor existing cancer communication campaigns. Information will be collected through focus group discussions involving the general public and health care professionals. Proposed activities will utilize HHS Health Communication Process methodology.

US Code: 42 USC 301 Name of Law: Public Health Service Act
   US Code: 42 USC 247b-17 Name of Law: Gynecologic Cancer Education and Awareness Act, Johanna's Law
  
None

Not associated with rulemaking

  76 FR 51035 08/17/2011
76 FR 66070 10/25/2011
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 2,592 2,592 0 0 0 0
Annual Time Burden (Hours) 1,814 1,814 0 0 0 0
Annual Cost Burden (Dollars) 52,843 52,843 0 0 0 0
No
No

$500,000
Yes Part B of Supporting Statement
Yes
No
No
No
Uncollected
Thelma Sims 4046394771

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
11/22/2011


© 2024 OMB.report | Privacy Policy